BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stanbio Laboratory Files Cross-Complaint In Superior Court Alleging Distortion Campaign By HemoCue


4/10/2006 12:14:13 PM

BOERNE, Texas, April 10 /PRNewswire/ -- Stanbio Laboratory, L.P., a leader in medical testing and diagnostic devices, has filed a cross-complaint alleging that its competitor, HemoCue, Inc., is engaged in unfair business practices and interference with Stanbio's business. The cross-complaint was filed Thursday, April 6, 2006 in the Superior Court of California, in Orange County.

According to the Stanbio cross-complaint, HemoCue has been telling customers and potential customers of Stanbio's hemoglobin meters and microcuvettes, that Stanbio is legally barred from selling those products as a result of a recent patent decision by a German court.

"That simply is not the case," said Micheal Lake, patent counsel for EKF Diagnostics, a party in the German case. "Stanbio is legally free to continue selling its hemoglobin meters and microcuvettes notwithstanding that decision. In fact, Stanbio was not even a party to that case and the German court's ruling has no legal effect on Stanbio in the United States."

Headquartered in Boerne, Texas, Stanbio manufactures and sells medical testing and diagnostic devices including clinical chemistry, pregnancy, drugs of abuse, serology, urinalysis, and point-of-care blood hemoglobin tests.

"This is a true case of David vs. Goliath. HemoCue, and its Swedish parent, HemoCue AB, are using their much greater size and resources to try and marginalize our business," said William Pippin, chief executive officer of Stanbio. "The lengths to which some companies will go to try to keep competitors out of the market and keep prices at artificially high levels is truly shocking."

The Stanbio cross-complaint is now a part of the public record and copies can be obtained by calling Amy Goldsmith, public relations consultant for Stanbio, at (310) 440-0646.

Since its founding in 1960, Stanbio has provided laboratories with high-quality, clinical diagnostic reagents, clinical instruments, and a wide variety of diagnostic products, which include pregnancy, drugs of abuse, serology, urinalysis, and microbiology assays. Stanbio also offers OEM and private labeling capabilities. Currently, Stanbio distributes products in over 70 countries worldwide. This year the company celebrates its 46th year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.

Stanbio Laboratory, L.P.

CONTACT: Amy Goldsmith, +1-310-440-0646, agoldsmith@gkcommunications.net,or Sara Shiffman, +1-310-271-2432, sshiffman@gkcommunications.net, both ofGK Communications, for Stanbio Laboratory, L.P.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES